Iterum Therapeutics plc (ITRM) Fundamentals

Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.
SHARE INFORMATION
Market Cap$ 14,802,383
Shares Outstanding12,233,374
Float12,069,212
Percent Float98.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -11.27
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions51
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months54,249
Institutional Holdings Percent3.2%
Institutional Sold Previous 3 Months113,573
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months46,425
Insider Holdings Percent7.0
Insider Sold Previous 3 Months11,699
Insider Shares Owned851,017
TRADING INFO
52 Week High$ 7.05
52 Week Low$ 0.60
52 Week High Change$ -73.84
21 Day Moving Average$ 1.0737
21 Day Extended Moving Average$ 1.1338
50 Day Moving Average$ 1.1395
50 Day Extended Moving Average$ 1.223
200 Day Moving Average$ 2.5056
200 Day Extended Moving Average$ 2.8745
10 Day Average Volume70,745
20 Day Average Volume116,893
30 Day Average Volume699,028
50 Day Average Volume434,471
Alpha-0.051874
Beta1.4118
Standard Deviation0.303715
R20.066272
7 Day Price Change$ 0.03
7 Day Percent Change2.54%
21 Day Price Change$ 0.28
21 Day Percent Change30.11%
30 Day Price Change$ 0.5053
30 Day Percent Change71.7%
Month to Date Price Change$ 0.37
Month to Date Percent Change44.05%
Quarter to Date Price Change$ 0.37
Quarter to Date Percent Change44.05%
180 Day Price Change$ -2.39
180 Day Percent Change-66.4%
200 Day Price Change$ -3.85
200 Day Percent Change-76.06%
Year to Date Price Change$ 0.37
Year to Date Percent Change44.05%

Iterum Therapeutics plc (ITRM) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.90
Int Coverage-12.40
Current Ratio8.90
Leverage Ratio1.90
Quick Ratio8.70
Long Term Debt To Capital0.48
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ -19,337,618
Price to Sales0.00
Price to Free Cash-1.00
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-51.21
Return on Equity-102.42
Return on Capital-59.53

Iterum Therapeutics plc (ITRM) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG
CEOCorey N. Fishman
Emplyoees13
Last AuditUQ
CIK0001659323
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressFitzwilliam Court, 1st Floor
Leeson Close
Dublin, 2
Websitehttps://www.iterumtx.com
Facsimile-
Telephone+353 16694820
EmailIR@iterumtx.com
Your Recent History
NASDAQ
ITRM
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230131 23:12:17